For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

We use cookies to make our site as useful as possible.

Our Cookie Policy explains how you can opt-out of the cookies we use.

If you continue without changing your cookie settings, we'll assume you’re happy with this.

Continue Continue

United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Diagnostic & Therapeutic Solutions
    Custom solutions & partnerships

    Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.

    Create custom solutions with us

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Supporting our customers and employees during the COVID-19 pandemic. Read more

Products by research area:
  • Cancer
  • Cardiovascular
  • Cell Biology
  • Epigenetics & Nuclear Signaling
  • Developmental Biology
  • Immunology
  • Metabolism
  • Microbiology
  • Neuroscience
  • Signal Transduction
  • Stem Cells

Abcam news

Jul-2020

Cancer Research UK and Abcam launch custom partnership to accelerate cancer research

Mar-2020

Abcam triumphs with industry award for knockout antibody validation success

Jan-2020

Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell’s Gene Editing Platform and Oncology Product Portfolio

Jan-2020

Abcam’s new CRISPR-Cas9 cell lines for target identification, validation and pathway discovery

Jan-2020

New JBC manuscript promotes industry-leading best practice guidance on antibody validation via Western blotting

Jan-2020

Abcam appoints Michael Baldock as Chief Financial Officer

Jan-2020

Abcam announces successful acquisition of Expedeon’s Proteomics and Immunology business, enhancing its conjugation capability

Dec-2019

Abcam and SomaServe announce comprehensive partnership to realise the potential of PolyNaut® ‘bionic’ nanoparticles for delivery to live cells

Dec-2019

Abcam Honoured As One Of The UK’s Best Places To Work In 2020; A Glassdoor Employees’ Choice Award Winner

Nov-2019

Abcam delivers outstanding performance in new Biocompare antibody market report

Nov-2019

Scientists poised to unlock their understanding of autophagy with new antibody-based insights

Nov-2019

Abcam agrees to acquire Expedeon’s Proteomics and Immunology business, expanding offerings into the fast-growing conjugation segment

Nov-2019

Abcam and BrickBio announce a partnership to incorporate conjugation-ready sites into recombinant antibodies across Abcam's portfolio

Nov-2019

Engineered knockout cell lysates for reproducible proteomic analysis

Jul-2019

Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knock-out Cell Lines and Lysates Portfolio

May-2019

New tissue clearing kits and reagents for faster, accurate 3D imaging

Apr-2019

NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler

Mar-2019

Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging

Mar-2019

Abcam wins the UK-China Business award

Feb-2019

Abcam moves to new purpose-built global headquarters

Feb-2019

Dr Michael Weiner wins CiteAb’s 2019 Lifetime achievement award

Jan-2019

Abcam expands custom services capabilities with the acquisition of Calico Biolabs

Jan-2019

Abcam and the LouLou Foundation partner to develop key research tools for CDKL5 deficiency disorder

Dec-2018

QIAGEN (Suzhou) and Abcam sign strategic MoU collaboration agreement to co-develop companion diagnostic (CDx) and in vitro diagnostic (IVD) reagents and kits for the Chinese market

Dec-2018

Abcam 'Most Admired Company' award

Oct-2018

Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development

Oct-2018

New PBS-only antibodies enable more flexible research

Jul-2018

Abcam Merck collaboration produces new PD-L1 antibody for immuno-oncology research

Jun-2018

Congratulations to Alan Hirzel, winner of European Mediscience Awards Chief Executive of the year award

Apr-2018

Abcam and Shuwen Biotech sign strategic MoU to establish global alliance for companion diagnostic (CDx) kit development

Feb-2018

New CatchPoint® SimpleStep® ELISA fluorescent 90-minute assay

Feb-2018

Introducing FirePlex®-HT High-throughput Multiplex Immunoassays – Delivering More Data from Precious Samples

Feb-2018

Abcam and Molecular Devices announce strategic collaboration

Jan-2018

Abcam wins another CiteAb award

Jan-2018

Abcam signs exclusive license agreement with Roche

Aug-2017

Abcam and TTP Labtech collaborate to develop sol-R reagent kits

Jul-2017

The University of Bath enters licensing agreement with Abcam to develop fluorescent detection probe kit for sugar-damaged proteins

Jun-2017

Abcam announces first international Epigenetics conference in South Korea

Jan-2017

Abcam wins two CiteAb awards

Nov-2016

Abcam wins Best Careers Website at the In-house Recruitment Awards

Jul-2016

New multiplex immunoassays with Firefly® particle technology

Apr-2016

Abcam enables faster drug and biomarker discovery with immunoassay research suite

Feb-2016

Congratulations to Jonathan Milner, winner of CiteAb’s Lifetime achievement award

Nov-2015

Abcam offers direct service to Singapore as part of deepening commitment to Asia-Pacific researchers

Nov-2015

Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership

Oct-2015

Abcam’s new anti-PD-L1 antibody enables deeper insights into cancer immunology research

Sep-2015

Abcam raises antibody validation standards to improve quality for life science researchers

Jun-2015

Appointment of Chief Legal Officer and Company Secretary

Jun-2015

Abcam launches multiplex miRNA profiling assays

Jan-2015

Abcam signs exclusive partnership agreement with A*STAR's Institute of Molecular and Cell Biology

Dec-2014

Sue Harris appointed as non-Executive Director on Abcam Board

Dec-2014

Abcam appoints Yvonne Chien as Chief Digital Officer

Nov-2014

Abcam wins 'Best Use of Digital Media' at Life Science Industry Awards

Sep-2014

Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia's Children's Cancer Institute

Sep-2014

Abcam plc announces appointment of new CEO and Board changes

Sep-2014

Abcam and Cell Marque sign global strategic marketing agreement for IVD IHC RabMAb® antibodies

Sep-2014

Abcam introduces exclusive range of highly validated antibody conjugates

Jun-2014

Abcam's CEO wins Mediscience award

Mar-2014

Abcam introduces Alexa Fluor® 680/790 secondary antibodies for fluorescent western blotting

Feb-2014

Abcam Announces Winner of 15 Discoveries Contest

Jan-2014

Abcam to open office in Shanghai, China

Dec-2013

Abcam wins 'Most Admired Company' award

Nov-2013

Abcam Introduces Alexa Fluor Secondary Antibodies

Oct-2013

Abcam Named AIM Company of the Year

Sep-2013

Abcam Launches SimpleStep ELISA Kits

Jun-2013

Abcam appoints Alan Hirzel as Chief Marketing Officer

Apr-2013

Abcam Welcomes Students from Cambridge Regional College

Mar-2013

Abcam donates an additional £45,000 to local charities

Dec-2012

Abcam helps contribute to growth of hi-tech sector in Cambridge, UK

Nov-2012

We have reached 100,000 products

Oct-2012

HRH The Duke of York visits Abcam to see the Cambridge Phenomenon in action

Sep-2012

Rabbit monoclonal antibodies, available from Abcam following acquisition of Epitomics

Jan-2012

New range of Biochemicals now available from Abcam

Sep-2011

Abcam acquires Ascent Scientific, a specialist provider of biochemicals

May-2011

Abcam acquires MitoSciences in deal which enhances immunoassay portfolio

Nov-2010

Jonathan Milner wins Entrepreneur of the Year award.

Jul-2010

Abcam's Jonathan Milner wins CEO of the Year

Jul-2010

300th employee hired

Mar-2010

Abcam wins 'Business of the Year 2009' at the Business Weekly East of England Awards.

Feb-2010

Abcam founder wins 'CEO of the Year' at Quoted Company Awards 2010

Jan-2010

Abcam and Cambridge Design Partnership develop innovative labeling solution

Oct-2009

Abcam named 'Company of the Year' at 2009 AIM Awards

Jun-2009

Abcam’s expansion continues with its fourth move on the Cambridge Science Park

Jul-2008

200th employee hired

May-2008

Licensing deal signed with Tepnel Life Sciences

Mar-2008

Grand setting for Japanese sub-dealer meetings

Nov-2007

Automated system to expand monoclonal production

Nov-2007

Abcam and leading antibody producer collaborate to make 12,000 rabbit polyclonals

Nov-2007

CLC bio customized software supports Abcam's monoclonal development capability

Nov-2007

Jeffrey Iliffe appointed as Chief Financial Officer

May-2007

Same day delivery in Cambridge UK

Mar-2007

Abcam to partner in the EPITRON project

Jan-2007

$2 to Médecins Sans Frontières for every new registration

Jul-2006

Extra Abpoints introduced for first Abreviews

Jul-2006

Appointment of Non-Executive Directors

Jun-2006

Winner of Best Newcomer in the European Mediscience awards

May-2006

Better antibodies, faster

Feb-2006

Winner of Private Company of the Year, Business Weekly East of England Business Awards 2005

Feb-2006

20,000+ products, 1,300 new lysates, Abpromise stats, Abupdate & news

Jan-2006

Fast Abpromise support, free loading control samples, Abupdate & news

Nov-2005

Search filter, conjugated loading controls, Abupdate & news

Sep-2005

Top forty position, Sunday Times Microsoft Tech Track

May-2005

US office on the move

Apr-2005

Queen's Award at first attempt

Apr-2005

More space

Dec-2004

A faster service

Oct-2004

First place in Deloitte's Fast 50

Sep-2004

50th employee hired

Sep-2004

Top forty position, Sunday Times Microsoft Tech Track

Jun-2004

Jim Warwick becomes Managing Director (Abcam Ltd)

Feb-2004

Collaboration deal struck with Purely Proteins

Jan-2004

A New Year's Honour

Dec-2003

High growth status recognised again, this time nationally

Oct-2003

Success in Deloitte's Regional Technology Fast 50

Sep-2003

Top twenty position, Sunday Times Arm Tech Track

Jul-2003

British royalty visits Abcam

May-2003

First overseas office established

Apr-2003

Jim Warwick (Technical Director) becomes full-time

Mar-2003

CEN Business Excellence Awards winner

Mar-2003

25th employee hired

Feb-2003

On the move again

Nov-2002

Deloitte Top 50 regional winner

Aug-2002

FedEx tie-up boosts customer support services

Jun-2001

Technical Director appointed

May-2001

UK Online for Business Award, highly commended

Oct-2000

CEN Millennium Business Excellence Awards finalist

May-2000

10th employee hired

Apr-2000

Finance Director appointed

Mar-2000

New premises on the Cambridge Science Park

Oct-1999

First (of many) awards

Oct-1998

Open for business

Get resources and offers direct to your inbox Sign up
A-Z by research area
  • Cancer
  • Cardiovascular
  • Cell biology
  • Developmental biology
  • Epigenetics & Nuclear signaling
  • Immunology
  • Metabolism
  • Microbiology
  • Neuroscience
  • Signal transduction
  • Stem cells
A-Z by product type
  • Primary antibodies
  • Secondary antibodies
  • Biochemicals
  • Isotype controls
  • Flow cytometry multi-color selector
  • Kits
  • Loading controls
  • Lysates
  • Peptides
  • Proteins
  • Slides
  • Tags and cell markers
  • Tools & Reagents
Help & support
  • Support
  • Make an Inquiry
  • Protocols & troubleshooting
  • Placing an order
  • RabMAb products
  • Biochemical product FAQs
  • Training
  • Browse by Target
Company
  • Corporate site
  • Investor relations
  • Company news
  • Careers
  • About us
  • Blog
Events
  • Tradeshows
  • Conferences
International websites
  • abcam.cn
  • abcam.co.jp

Join with us

  • LinkedIn
  • facebook
  • Twitter
  • YouTube
  • Terms of sale
  • Website terms of use
  • Cookie policy
  • Privacy policy
  • Legal
  • Modern slavery statement
© 1998-2021 Abcam plc. All rights reserved.